Biliary System Malignancies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-09-07
Clinical Trial Update: Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System. [Phase 2]
Phase 2 trial investigating tislelizumab plus lenvatinib and gemox for potentially resectable locally advanced malignant tumors of the bilia…